Immunogenicity and Safety of mRNA Anti-SARS-CoV-2 Vaccines in Patients with Systemic Lupus Erythematosus

Vaccination is the most effective preventive measure to control the spread of COVID-19 and reduce associated complications. This study aims to evaluate the efficacy and safety of mRNA COVID-19 vaccines in patients with systemic lupus erythematosus (SLE). A total of 41 adult SLE patients receiving tw...

Descripción completa

Detalles Bibliográficos
Autores principales: Mormile, Ilaria, Della Casa, Francesca, Petraroli, Angelica, Furno, Alessandro, Granata, Francescopaolo, Portella, Giuseppe, Rossi, Francesca Wanda, de Paulis, Amato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416775/
https://www.ncbi.nlm.nih.gov/pubmed/36016108
http://dx.doi.org/10.3390/vaccines10081221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416775/
https://www.ncbi.nlm.nih.gov/pubmed/36016108
http://dx.doi.org/10.3390/vaccines10081221

Ejemplares similares